Turn clinical progress into commercial performance.

We strengthen life sciences organizations to better make and execute the commercial decisions that matter, from early asset planning through launch and sustained growth, building the strategies, operating models, and capabilities teams can carry forward.

Schedule a Conversation

Pre-Launch & Early Commercial Planning

Quantify commercial potential before you commit capital.

We assess assets and portfolios through market sizing, valuation, scenario forecasting, and stakeholder insights. The result is a clearer view of product potential, indication priorities, and the commercial evidence needed to inform R&D and investment decisions.

Related Case Studies

Opportunity Assessment and Indication Sequencing Strategy

Development of the commercial potential, indication sequencing strategy, and pricing strategy to maximize the commercial opportunity for a novel rare disease therapy.

R&D Gene Therapy Portfolio Strategy Formation

Enhancement of position in the marketplace by leading the formation of a mid-size biopharma company's R&D portfolio strategy for its gene therapy division.

Brand Strategy & Analytics

Sharpen positioning and align teams around the brand.

We combine situational analysis, HCP and patient insights, competitive wargaming, and brand workshops to shape positioning, messaging, and tactical priorities. The work informs KOL strategies, brand plans, and functional playbooks, strengthening differentiation and aligning execution.

Related Case Studies

New Product Brand Planning

Enhancement of position in the marketplace by leading the formation of a mid-size biopharma company's R&D portfolio strategy for its gene therapy division.

Patient Outflows and Solution Assessment

Identification of patient journey outflows and evaluation of tech solutions to close care gaps for a rare disease treatment.

Market Access & Pricing

Build access strategies that protect launch value.

We translate clinical differentiation into payer-relevant value stories, pricing strategies, and market-specific access plans. Through stakeholder research, analogue benchmarking, and pricing models, teams make evidence-based access decisions across markets.

Related Case Studies

Global Market Access Strategy

Development of country‑level market access roadmaps using pricing/access analogue assessment for a cardiology rare disease asset.

Value Proposition and Franchise Optimization

Tailoring of a value proposition and access strategy for a new oncology therapy in Newly Diagnosed Multiple Myeloma (NDMM).

Revenue Acceleration

Bring rigor to the decisions that shape portfolio growth.

We identify and evaluate external innovation opportunities using scientific, commercial, and financial analysis. From target screening through diligence, valuation, and business cases, teams make sharper in-licensing, M&A, and partnership decisions.

Related Case Studies

Gene Therapy Program Search and Evaluation in Select Therapeutic and Disease Areas

Conduction of search and evaluation for >500 gene-therapy programs, identifying high priority assets aligned to client's R&D portfolio strategy.

Pediatric Therapeutics Business Development Assessment

Generation of the opportunity universe and prioritization of therapeutic classes to inform a client's decision to enter a new market while complementing their current portfolio.

Commercial Excellence

Build an operating model that turns strategy into execution.

We design go-to-market strategies, operating models and launch archetypes, and performance systems that strengthen commercial execution. Your teams establish the roles, processes, and measures that run the model and sustain it over time.

Related Case Studies

Early Commercialization Strategy and Go-to-Market Model Design & Development

Support of commercialization for two gene therapy assets by defining the early commercial strategy and proposing the optimal go-to-market model.

Strategic and Tactical Launch Support

Development of a comprehensive launch playbook and organizational model to support a novel autoimmune therapy for a company's first product, enabling a successful market entry and company exit.

Vendor Governance Redesign for Offshored Regulatory Operations

Commercial Innovation & New Business Models

Build new paths to commercial value.

We design and operationalize digital and business model innovation aligned to corporate priorities, connecting strategy, data, technology, workflows, and adoption so new approaches can move from concept into practice.

Related Case Studies

Move from commercial decision to execution.

Whether the challenge is launch readiness, pricing, portfolio growth, or commercial execution, we define the path forward with you, implement it, and build the capability to sustain it.

Schedule a Conversation

Explore Our Perspectives

See how we’re thinking about the decisions shaping launch, access, growth, and commercial execution.

Explore Our Perspectives

Turn clinical progress into commercial performance.

Explore Our Commercial Capabilities

Pre-Launch & Early Commercial Planning

Brand Strategy & Analytics

Market Access & Pricing

Revenue Acceleration

Commercial Excellence

Commercial Innovation & New Business Models

From Our Perspectives

Decision Latency Is a Growth Strategy Problem: Redesigning Portfolio Governance for Speed and Discipline

AI Is Not Ready to Be the Decision-Maker, And Pretending Otherwise Is the Real Risk

Stop Asking Build vs. Buy: Most Biotechs Don't Have an AI Strategy at All

Move from commercial decision to execution.

Explore Our Perspectives

Explore Our Perspectives